Oramed Pharmaceuticals Inc. (ORMP) Social Stream
ORAMED PHARMACEUTICALS INC (ORMP) Price Targets From Analysts
Use the tables below to see what analysts covering ORAMED PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 3 | $35 | $17 | $26.25 | $2.34 | 1021.79% |
| 2021-11-10 | 4 | $38 | $17 | $30 | $2.34 | 1182.05% |
| 2022-01-18 | 3 | $38 | $30 | $33.75 | $2.34 | 1342.31% |
| 2022-04-13 | 4 | $38 | $20 | $31 | $2.34 | 1224.79% |
| 2022-04-27 | 3 | $38 | $20 | $31 | $2.34 | 1224.79% |
| 2022-11-16 | 3 | $38 | $20 | $30 | $2.34 | 1182.05% |
| 2022-11-21 | 3 | $32 | $20 | $26.75 | $2.34 | 1043.16% |
| 2023-01-03 | 2 | $32 | $20 | $26.75 | $2.34 | 1043.16% |
| 2023-01-13 | 3 | $30 | $3 | $15.75 | $2.34 | 573.08% |
| 2023-01-25 | 2 | $30 | $2.8 | $11.933 | $2.34 | 409.96% |
| 2023-10-05 | 2 | $4.3 | $3 | $3.65 | $2.34 | 55.98% |
The Trend in the Analyst Price Target
Over the past 25 months, ORMP's average price target has gone down $19.35.
Over the past 39 weeks, ORMP's average upside potential has been 245.94%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-03 | 2 | 32.0 | 20.0 | 26.750 | 12.40 | 115.73% |
| 2023-01-25 | 3 | 30.0 | 2.8 | 10.200 | 2.06 | 395.15% |
| 2023-01-25 | 3 | 30.0 | 2.8 | 11.933 | 2.06 | 479.27% |
| 2023-01-25 | 3 | 3.0 | 2.8 | 2.900 | 2.06 | 40.78% |
| 2023-10-05 | 2 | 4.3 | 3.0 | 3.650 | 2.39 | 52.72% |
ORMP Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 2 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 23 months, ORMP's average broker recommendation rating worsened by 1.75.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORMP as an investment opportunity.
- In the context of all US stocks, ORAMED PHARMACEUTICALS INC's number of analysts covering the stock is greater than 110.41% of them.
- ORAMED PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1385.93% of all US stocks.
- In the context of stocks in the small market cap category, ORAMED PHARMACEUTICALS INC's average analyst price target is higher than 841.22% of them.
- In terms of how ORAMED PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -566.79% of that group.
In the Pharmaceutical Products industry, FBRX, BYSI, and CKPT are the three stocks most similar to ORAMED PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding ORMP using the data that counts. Try POWR Ratings for free.